900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy by Quanyuan He, Christian E Laing, Stewart E Abbot, Tony Collins, Meghan Verschoor, Chantal G Martin, Michael Ciancanelli

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy by Xiaokui eZhang, Lin eKang, Vanessa eVoskinarian-Berse, Eric eLaw, Tiffany eReddin, Mohit eBhatia, Alexandra eHariri, Yuhong eNing, David eDong, Timothy eMaguire, Martin eYarmush, Wolfgang eHofgartner, Stewart eAbbot, Robert eHariri

Get full text

178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy by Li Liu, Simon Turcotte, Shari Pilon-Thomas, Doris Wiener, Brian Czerniecki, Matthew Beatty, Larissa Pikor, Urminder Singh, Christian E Laing, Jacob Gibson, Anna Kluew, Mahdi Golkaram, Sven Bilke, Nathalie Brassard, Stewart E Abbot, Timothy J Langer, Grace DeSantis, Michael J Ciancanelli, Jeff H Tsai

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models by Kevin P Nishimoto, Taylor Barca, Aruna Azameera, Amani Makkouk, Jason M Romero, Lu Bai, Mary M Brodey, Jackie Kennedy‐Wilde, Hui Shao, Stephanie Papaioannou, Amy Doan, Cynthia Masri, Ngoc T Hoang, Hayden Tessman, Vidhya Dhevi Ramanathan, Ana Giner‐Rubio, Frank Delfino, Kriti Sharma, Kevin Bray, Matthew Hoopes, Daulet Satpayev, Ranjita Sengupta, Marissa Herrman, Stewart E Abbot, Blake T Aftab, Zili An, Swapna Panuganti, Sandra M Hayes

Get full text